192 related articles for article (PubMed ID: 34152516)
1. Systematic truncations of chromosome 4 and their responses to antifungals in Candida albicans.
Uddin W; Dhabalia D; Prakash SMU; Kabir MA
J Genet Eng Biotechnol; 2021 Jun; 19(1):92. PubMed ID: 34152516
[TBL] [Abstract][Full Text] [Related]
2. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and Antifungal Susceptibility of the Emerging Fungal Species,
Sikora M; Kuthan R; Piskorska-Malolepsza K; Golas-Pradzynska M; Domański D; Augustynowicz-Kopeć E; Swoboda-Kopec E
Pol J Microbiol; 2019 Sep; 68(3):303-308. PubMed ID: 31880875
[TBL] [Abstract][Full Text] [Related]
4. Minimum inhibitory concentrations of amphotericin B, azoles and caspofungin against Candida species are reduced by farnesol.
Cordeiro RA; Teixeira CE; Brilhante RS; Castelo-Branco DS; Paiva MA; Giffoni Leite JJ; Lima DT; Monteiro AJ; Sidrim JJ; Rocha MF
Med Mycol; 2013 Jan; 51(1):53-9. PubMed ID: 22712455
[TBL] [Abstract][Full Text] [Related]
5. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
Karabıçak N; Alem N
Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
[TBL] [Abstract][Full Text] [Related]
6. Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans.
Castanheira M; Deshpande LM; Davis AP; Rhomberg PR; Pfaller MA
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784671
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort.
Samaranayake YH; Samaranayake LP; Tsang PC; Wong KH; Yeung KW
J Oral Pathol Med; 2001 Jul; 30(6):336-46. PubMed ID: 11459319
[TBL] [Abstract][Full Text] [Related]
8. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
Jensen RH
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
[TBL] [Abstract][Full Text] [Related]
9. Anti-candidal activity of essential oils alone and in combination with amphotericin B or fluconazole against multi-drug resistant isolates of Candida albicans.
Khan MS; Malik A; Ahmad I
Med Mycol; 2012 Jan; 50(1):33-42. PubMed ID: 21756200
[TBL] [Abstract][Full Text] [Related]
10. Activity of Diosgenyl 2-amino-2-deoxy-β-D-glucopyranoside, its Hydrochloride, and N,N-dialkyl Derivatives Against Non-albicans Candida Isolates.
Dawgul MA; Grzywacz D; Liberek B; Kamysz W; Myszka H
Med Chem; 2018; 14(5):460-467. PubMed ID: 29485003
[TBL] [Abstract][Full Text] [Related]
11.
Nishimoto AT; Wiederhold NP; Flowers SA; Zhang Q; Kelly SL; Morschhäuser J; Yates CM; Hoekstra WJ; Schotzinger RJ; Garvey EP; Rogers PD
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910896
[TBL] [Abstract][Full Text] [Related]
12. Increasing Susceptibility of Drug-Resistant
Sharafutdinov IS; Ozhegov GD; Sabirova AE; Novikova VV; Lisovskaya SA; Khabibrakhmanova AM; Kurbangalieva AR; Bogachev MI; Kayumov AR
Molecules; 2020 Feb; 25(3):. PubMed ID: 32024254
[TBL] [Abstract][Full Text] [Related]
13. Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non-cancer patient population: is there a correlation between in-vitro resistance to fluconazole and the outcome of fungemia?
Kovacicova G; Krupova Y; Lovaszova M; Roidova A; Trupl J; Liskova A; Hanzen J; Milosovic P; Lamosova M; Macekova L; Szovenyiova Z; Purgelova A; Obertik T; Bille J; Krcmery V
J Infect Chemother; 2000 Dec; 6(4):216-21. PubMed ID: 11810569
[TBL] [Abstract][Full Text] [Related]
14. In vitro inhibitory effects of farnesol and interactions between farnesol and antifungals against biofilms of Candida albicans resistant strains.
Xia J; Qian F; Xu W; Zhang Z; Wei X
Biofouling; 2017 Apr; 33(4):283-293. PubMed ID: 28317391
[TBL] [Abstract][Full Text] [Related]
15. Synergistic Antifungal Activity of Chitosan with Fluconazole against
Lo WH; Deng FS; Chang CJ; Lin CH
Molecules; 2020 Nov; 25(21):. PubMed ID: 33153228
[TBL] [Abstract][Full Text] [Related]
16. [Investigation of the expression levels of efflux pumps in fluconazole-resistant Candida albicans isolates].
Gulat S; Doluca Dereli M
Mikrobiyol Bul; 2014 Apr; 48(2):325-34. PubMed ID: 24819270
[TBL] [Abstract][Full Text] [Related]
17. A chromosome 4 trisomy contributes to increased fluconazole resistance in a clinical isolate of Candida albicans.
Anderson MZ; Saha A; Haseeb A; Bennett RJ
Microbiology (Reading); 2017 Jun; 163(6):856-865. PubMed ID: 28640746
[TBL] [Abstract][Full Text] [Related]
18. Proof of Concept for MBT ASTRA, a Rapid Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS)-Based Method To Detect Caspofungin Resistance in Candida albicans and Candida glabrata.
Vatanshenassan M; Boekhout T; Lass-Flörl C; Lackner M; Schubert S; Kostrzewa M; Sparbier K
J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 30021820
[TBL] [Abstract][Full Text] [Related]
19. Necessity to identify candida species accurately with minimum inhibitory concentration determination in each case of bloodstream infections.
Pandey N; Gupta MK; Paul P; Tilak R
J Infect Public Health; 2020 May; 13(5):753-758. PubMed ID: 31899133
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures].
Ozcan SK; Mutlu B; Dündar D; Willke A
Mikrobiyol Bul; 2010 Apr; 44(2):263-71. PubMed ID: 20549961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]